Alkem Laboratories share price down marginally in the opening trade on March 23 despite the company received DCGI approval to manufacture and market Semaglutide Injection in India.At 09:21am, Alkem Laboratories was quoting at Rs 5,204.05, down Rs 53.70, or 1.02 percent, on the BSE.The company has launched its semaglutide pre-filled disposable injection pen at a price starting Rs 1,800 for a monthâ...

Let's catch up on the latest news from the stock market. From significant investments to major deals, quarterly earnings, order wins, and acquisitions, here’s a quick look at which stocks will be in focus in today's trade:Quarterly EarningsOla Electric Mobility Q3 (Consolidated YoY)Loss narrows to Rs 487 crore Vs loss of Rs 564 croreRevenue sinks 55% to Rs 470 crore Vs Rs 1,045 crorePrecision Wi...

Let's catch up on the latest news from the stock market. From significant investments to major deals, quarterly earnings, and appointments, here’s a quick look at which stocks will be in focus in today's trade:Results TodayBajaj Finserv, Tata Power Company, Biocon, Bosch, Awfis Space Solutions, Balrampur Chini Mills, Bharat Forge, Bikaji Foods International, Container Corporation of India, Edelw...

Stocks to watch, 4 June: Stocks like Sun Pharmaceutical Industries, Zydus Lifesciences, Techno Electric & Engineering Company, R Systems International, NMDC, Tata Technologies, Indegene, Aditya Birla Fashion and Retail, Alkem Laboratories, HDFC Bank, Wipro, Servotech Renewable Power Systems, and Scoda Tubes will be in focus on June 4.Let's catch up on the latest news from the stock market. From si...

Alkem Laboratories on May 29 reported a net profit of nearly Rs 306 crore for the fourth quarter of the financial year 2025. This marks a 4.2 percent rise from the Rs 294 crore net profit reported in the corresponding quarter of the previous financial year. The shares of the company tumbled nearly 4 percent on May 30 to trade at Rs 5,099 apiece.The Mumbai-based pharmaceutical company's total reven...